Douglas B Johnson, Michael B Atkins, Cassandra Hennessy, Trisha Wise-Draper, Hannah Heilman, Joy Awosika, Ziad Bakouny, Chris Labaki, Renee Maria Saliby, Clara Hwang, Sunny R K Singh, Nino Balanchivadze, Christopher R Friese, Leslie A Fecher, James J Yoon, Brandon Hayes-Lattin, Mehmet A Bilen, Cecilia A Castellano, Gary H Lyman, Lisa Tachiki, Sumit A Shah, Michael J Glover, Daniel B Flora, Elizabeth Wulff-Burchfield, Anup Kasi, Saqib H Abbasi, Dimitrios Farmakiotis, Kendra Viera, Elizabeth J Klein, Lisa B Weissman, Chinmay Jani, Matthew Puc, Catherine C Fahey, Daniel Y Reuben, Sanjay Mishra, Alicia Beeghly-Fadiel, Benjamin French, Jeremy L Warner
INTRODUCTION: COVID-19 particularly impacted patients with co-morbid conditions, including cancer. Patients with melanoma have not been specifically studied in large numbers. Here, we sought to identify factors that associated with COVID-19 severity among patients with melanoma, particularly assessing outcomes of patients on active targeted or immune therapy. METHODS: Using the COVID-19 and Cancer Consortium (CCC19) registry, we identified 307 patients with melanoma diagnosed with COVID-19...
March 23, 2023: BMC Cancer